StonvexLoading…
StonvexStonvexStonvexCore line items from SMCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $21.97B | $14.99B | $7.12B | $5.20B |
Operating Income | $1.25B | $1.21B | $761.14M | $335.17M |
Net Income | $1.05B | $1.15B | $640.00M | $285.16M |
EPS (Diluted) | $1.68 | $1.92 | $1.14 | $0.53 |
Total Assets | $14.02B | $9.83B | $3.67B | $3.21B |
Total Liabilities | $7.72B | $4.41B | $1.70B | $1.78B |
Cash & Equivalents | $5.17B | $1.67B | $440.46M | $267.40M |
Free Cash Flow OCF − CapEx | $1.53B | $-2.61B | $626.79M | $-485.98M |
Shares Outstanding | 594.14M | 588.09M | 529.01M | 52.31M |